Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank67
3Y CAGR+4.1%
5Y CAGR+21.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.1%/yr
Annual compound
5Y CAGR
+21.6%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $34.19M | -18.0% |
| 2024 | $41.68M | +12.0% |
| 2023 | $37.20M | +22.7% |
| 2022 | $30.32M | +63.3% |
| 2021 | $18.57M | +44.1% |
| 2020 | $12.89M | -10.4% |
| 2019 | $14.38M | - |